Member Info for chester18

When I said that Angle is "as secure as they come", I'm paying tribute to the amount of time and the steadfast belief of the BOD and especially AN's focus on 'This product will change the face of Blood Biopsy for Cancer patients'.

What is now virtually a done deal of having an FDA approved device has up to now been a dream driven by a very dedicated team. They realised along the way that setting up Clinical Services Labs in the UK and USA could actually become a multi million pound business in itself.

Give it two years and the income from those and future Labs will produce a share price considerably more than todays £ 1.145 ( £247m MCap ). Make your own number up for the potential turnover and multiply by a minimum of 10.

The other solid fact is the amount of issued shares, 215 million, that is also a very low number set against the future potential revenues of an approved Parsortix system plus the Labs.

I think you could dare to call me 'positive' where Angle is concerned.

Chester.

Looks like a news opportunity for the market makers to drop the price and create a market, as is their job.

News is probably just a week or two away so in the meantime I expect the price to roll around but it seems to magically return to the opening price day after day after day. I my opinion, not the kind of time to be playing 'Chicken' with your shares.

Hold on tight because the RNS we all want could land at any time.

Chester.

Hi Bojo2020

Angle is a very exciting prospect because it ticks every box in terms of an investment that is as secure as they come. That's due to the Clinical Services Labs.
Those facilities can and will produce income that I believe will be more than enough to cover todays share price.

Once the FDA give their blessing to Parsortix it will take off faster than Elon Musk's Space X....lol

Chester

C7 / C11

Apparently the Dream is Still a Reality...............

Wishing You Good Luck in the Final......

Chester

The fact that the MM's have been very stingy on the buying side tells me that most of the accumulated sells over the last four or five trading days have been filling that 800k Plus the 200k Plus Vulpes 400k on Friday.

The price was dropped rapidly last Wednesday and Thursday and it looked certain we were headed under 20p when the Vulpes buy landed and reversed the price direction. I would hazard a guess that these three large trades are all filled orders but the 217k trade does feel like a sell.

Last point, if they were all sells we would definitely be down around 20p going South ......

Chester.

Hi C7

Are we putting that 217k @ 23p down as a Sell ?

The buys going through at that time were 23.18p & 23.21p.
Could have been a filled order due to its size but the MM's have struggled for stock these last two days.

Chester

12:54pm 210,000 buy @ 23.25p nearly £49k

Someone sees our prospects as very positive.

Chester.

Hi bobbust

With the total news blackout and virtually no re-tweets from Scancell it does feel like we are gearing up for some important news.

Also to bear in mind that the next RNS from Scancell could be to do with the Modi 1 or the Scib / Keytruda trial.

Must admit though, it would be fantastic to be backed to the hilt by CEPI.

Chester.

That's a large chunk of cash to invest in any AIM share but to be honest I wish I had that kind of money to split between AGL and SCLP.

The submission to the FDA of the extra data they required is due in May, do we think Angle will RNS the fact that its been sent?

Chester

Hi GF123

We are certainly moving into the Red Zone as far as Covidity is concerned.
Whoever produces an affordable universal vaccine that prevents all the worry, stress and human costs associated with escaped variants will be hailed as heroes.
Could Covidity fit that title? Well let's hope when its put through its paces it stands up to the challenge.

If Covidity can attack the virus in its Nucleocapsid and negate the Spike Protein mutations it will be an amazing development for Scancell and its investors.
The exciting bit is that we are now very close to finding out whether it is a 'Vision or a Reality'.

Chester.

Hi ICB888

After being patient for what seems an age we are now approaching the sharp end of this wait.
Scancell is fantastic at keeping a very tight ship on news and we never quite know what is just over the horizon, so the heads up from Vulpes is really welcomed.

There are many long term holders here that understand the depth and breadth of Scancells IP which is covered by approved patents or in the process of gaining approval. When the SP was at 5.5p I posted along the lines of 'Why would you not take advantage of such a low price' knowing only of the potential cancer vaccines. As Crumbs has said on many occasions, the successful launch of the Covidity platform will actually also validate the Immunobody, AvidiMab and the New Peptide Delivery Platforms all in one go.

As Inanaco would say 'Tick Tock'......

Chester.

What ever happens short term some big inflection points are coming in the next 3 / 6 months.

The next two drill core results, Mid June and End July will both have a positive affect on the share price and also start to inform us about the move to a larger Inferred MRE. When we reach the 'PFS release' that is when the real move northwards will happen.

The share price will react to details coming from the company and maybe SD has his eye on something but also we may have a few nice surprises from the exploration drilling either the Juri JV or one of our 100% licenses.

Chester.

Morning All,

Based on the Vulpes 'Confidence' buy on Friday I've added just over 115k shares this morning.
I am sharing this info with the board because I'm always very positive towards Scancell but I also want to show that I "put my money where my mouth is" as the saying goes.

Any concerns I had with the lack of news were dispelled because who Vulpes are and their relationship with Scancell allowing them to know things are going well. I'm not saying they know every intimate detail about the possible trials or dates but they will know enough, making their purchase a massive green light for me.

Chester.

As private investors we are rarely given a 'heads up' telling us that our investment is in good shape and primed ready to rise. Well the Vulpes ( Wiggle Diggle ) purchase is that very rare beast.

It points to there being no major hick-ups in advancing at the very least one of our Clinical Trials.

As a sign posts it reads :
"Yes, Scancell is going to announce positive Trial status, Very Soon".

In a matter of 'Weeks', ( and Not Sky News Weeks but Proper Reality Weeks )..... : )

Chester.

Thanks moonparty

The timing of this purchase by Vulpes causes a big change to my assumption of when we will hear news from Scancell. Up until now I was confident that news would land by mid May but this now makes me believe we are at least month from that pivitol news.

If Vulpes bought this amount and a positive RNS landed next week there would be grounds for insider trading so this suggests to me that the news we so desperately want to hear is at least four weeks away.

On the extremely positive side, there mustn't be any technical hitches with the science because they have bought these 400,000 shares. My one constant fear was that the new delivery platform was causing some technical delays but I'm now confident that we are are just waiting for the whole trials ready details, Clinical Sites, Official Documents and Approval to Begin.

The one thing that this buy points to is, Vulpes is showing us their confidence in the future of Scancell. That is Loud and Clear.....

Chester.

So the Vulpes Fund has bought the shares and not Martin Diggle because if it were Mr Diggle himself, that would mean he must not know any price sensitive information at this time. However the fund he is associated with is able to buy with impunity because they don't know anything ? Still not sure how that works.

Still it makes me believe they have a front row seat and can react accordingly.

However, the fact that they are buying £80k's worth is very good news which ever way I slice it.

Chester.

So how do we interpret that nugget of information.

'Director buying' so no news imminent but 'Director buying' at 20p so suggesting that this price is cheap and the future looks rosey....!!!

Confused.Chester

The fact that the MRE has not been altered this time around means that the upgrade will now happen either in mid June's Newcrest Interim report or be held back for a huge upgrade in July's Quarterly.

The next 6 weeks will be all about the exploration drilling in the Juri JV and Scallywag plus any left field news emanating from Shaun Day's overview of our existing licences or dare I say 'deals' that he feels adds to the development of GGP into a multi headed mining Co.

Chester.

When Scancell announce that their Covidity Project is finally ready to go into clinical trials you can be assured that the science behind that decision is as robust as possible and is fit for purpose. This pandemic is a huge global problem and will take many vaccines, especially those targeting the Nucleus of the virus to allow us all some semblance of normality.

The task of our scientists is to defeat all possible future variants, my hope is that the Covidity Project proves to be the right technology at the right time.

Chester.

Good night Tig

I do think you can sleep soundly, dreaming of at least 16M ounces.
If we don't have an upgrade in Indicated this time around the 28th July report is going to 'blow the bloody doors off'......... I would say..

Chester.